Rhinovirus and airway allergy

Rhinoviruses cause the majority of common colds, which often provoke wheezing in patients with asthma. The precise mechanisms responsible for the rhinovirus infection-induced exacerbations of bronchial asthma remain uncertain. However, several reports have demonstrated airway hyperresponsiveness, in...

Full description

Bibliographic Details
Main Authors: Mutsuo Yamaya, Hidetada Sasaki
Format: Article
Language:English
Published: Elsevier 2004-01-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015310960
_version_ 1818622217138733056
author Mutsuo Yamaya
Hidetada Sasaki
author_facet Mutsuo Yamaya
Hidetada Sasaki
author_sort Mutsuo Yamaya
collection DOAJ
description Rhinoviruses cause the majority of common colds, which often provoke wheezing in patients with asthma. The precise mechanisms responsible for the rhinovirus infection-induced exacerbations of bronchial asthma remain uncertain. However, several reports have demonstrated airway hyperresponsiveness, increases in chemical mediators in airway secretions, such as kinin and histamine, and airway inflammation in patients with bronchial asthma after rhinovirus infection. Rhinovirus infection induces the accumulation of inflammatory cells in airway mucosa and submucosa, including neutrophils, lymphocytes and eosinophils. Rhinovirus affects the barrier function of airway epithelial cells and activates airway epithelial cells and other cells in the lung to produce proinflammatory cytokines, including various types of interleukins, granulocyte-macrophage colony stimulating factor and RANTES, and histamine. Rhinovirus also stimulates the expression of intercellular adhesion molecule-1 (ICAM-1) and low-density lipoprotein receptors in the airway epithelium, receptors for major and minor rhinoviruses. Rhinovirus infection is inhibited by treatment with soluble ICAM-1 and by the reduction of ICAM-1 expression in airway epithelial cells after treatment with either glucocorticoid or erythromycin. Both soluble ICAM-1 and erythromycin have been reported to reduce the symptoms of common colds. Herein, we review the pathogenesis and management of rhinovirus infection-induced exacerbation of bronchial asthma and the relationship between rhinovirus infection and airway allergy.
first_indexed 2024-12-16T18:21:39Z
format Article
id doaj.art-87a7893f5c9048faad6a87c468006849
institution Directory Open Access Journal
issn 1323-8930
language English
last_indexed 2024-12-16T18:21:39Z
publishDate 2004-01-01
publisher Elsevier
record_format Article
series Allergology International
spelling doaj.art-87a7893f5c9048faad6a87c4680068492022-12-21T22:21:32ZengElsevierAllergology International1323-89302004-01-01532374510.1111/j.1440-1592.2004.00330.xRhinovirus and airway allergyMutsuo YamayaHidetada SasakiRhinoviruses cause the majority of common colds, which often provoke wheezing in patients with asthma. The precise mechanisms responsible for the rhinovirus infection-induced exacerbations of bronchial asthma remain uncertain. However, several reports have demonstrated airway hyperresponsiveness, increases in chemical mediators in airway secretions, such as kinin and histamine, and airway inflammation in patients with bronchial asthma after rhinovirus infection. Rhinovirus infection induces the accumulation of inflammatory cells in airway mucosa and submucosa, including neutrophils, lymphocytes and eosinophils. Rhinovirus affects the barrier function of airway epithelial cells and activates airway epithelial cells and other cells in the lung to produce proinflammatory cytokines, including various types of interleukins, granulocyte-macrophage colony stimulating factor and RANTES, and histamine. Rhinovirus also stimulates the expression of intercellular adhesion molecule-1 (ICAM-1) and low-density lipoprotein receptors in the airway epithelium, receptors for major and minor rhinoviruses. Rhinovirus infection is inhibited by treatment with soluble ICAM-1 and by the reduction of ICAM-1 expression in airway epithelial cells after treatment with either glucocorticoid or erythromycin. Both soluble ICAM-1 and erythromycin have been reported to reduce the symptoms of common colds. Herein, we review the pathogenesis and management of rhinovirus infection-induced exacerbation of bronchial asthma and the relationship between rhinovirus infection and airway allergy.http://www.sciencedirect.com/science/article/pii/S1323893015310960airway allergyairway hyperresponsivenessairway inflammationbronchial asthmarhinovirus
spellingShingle Mutsuo Yamaya
Hidetada Sasaki
Rhinovirus and airway allergy
Allergology International
airway allergy
airway hyperresponsiveness
airway inflammation
bronchial asthma
rhinovirus
title Rhinovirus and airway allergy
title_full Rhinovirus and airway allergy
title_fullStr Rhinovirus and airway allergy
title_full_unstemmed Rhinovirus and airway allergy
title_short Rhinovirus and airway allergy
title_sort rhinovirus and airway allergy
topic airway allergy
airway hyperresponsiveness
airway inflammation
bronchial asthma
rhinovirus
url http://www.sciencedirect.com/science/article/pii/S1323893015310960
work_keys_str_mv AT mutsuoyamaya rhinovirusandairwayallergy
AT hidetadasasaki rhinovirusandairwayallergy